Aurobindo’s generic tobramycin inhalation solution is used to treat cystic fibrosis in adults and pediatric patients age 6 years old and older with Pseudomonas aeruginosa.
Hikma submitted an amendment to its application, which reflects enhanced packaging controls, to meet new industry standards adopted since the initial submission of its ANDA application.